Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2010
11/16/2010US7834182 histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine
11/16/2010US7834061 Process for producing 1,4-dihydroxy-2-naphthoic acid
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834033 administering a tumor necrosis factor inhibitor; angiogenesis inhibitor; treating inflammatory, and autoimmune diseases
11/16/2010US7833993 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia
11/16/2010US7833991 Amine compound and use thereof
11/16/2010CA2479084C Vdac regulator
11/16/2010CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase
11/16/2010CA2452114C Tgf-.beta. superfamily production/secretion promoter
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2415643C Pharmaceutical composition for oral use with improved absorption
11/16/2010CA2405479C Method of inhibiting the expression of inflammatory cytokines and chemokines
11/16/2010CA2396824C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
11/16/2010CA2389165C Substituted indoles for modulating nfkb activity
11/16/2010CA2330659C Using ngali nut oil to treat/relieve manifestations of arthritis and other similar conditions
11/16/2010CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition
11/11/2010WO2010129917A2 Anti-cd100 antibodies and methods for using the same
11/11/2010WO2010129053A2 Egfr inhibitors and methods of treating disorders
11/11/2010WO2010128401A1 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
11/11/2010WO2009135581A9 Nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
11/11/2010WO2009016498A8 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
11/11/2010US20100287637 Methods of blocking tissue destruction by autoreactive t cells
11/11/2010US20100286268 Topical composition
11/11/2010US20100286266 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents
11/11/2010US20100286233 Peripheral and neural inflammatory crosstalk
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286207 Novel 2-Oxo-Heterocyclic Compounds And The Pharmaceutical Compositions Comprising The Same
11/11/2010US20100286195 Novel benzooxazol-and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/11/2010US20100286190 Certain substituted ureas, as modulators of kinase activity
11/11/2010US20100286189 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
11/11/2010US20100286183 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
11/11/2010US20100286114 Hedgehog pathway antagonists and therapeutic applications thereof
11/11/2010US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses
11/11/2010US20100286086 Composition for the treatment of osteoarthritis
11/11/2010US20100286063 GNRH agonist combination drugs
11/11/2010US20100286060 Specific binding agents of human angiopoeitin-2
11/11/2010US20100286025 Synthetic apolipoprotein e mimicking polypeptides and methods of use
11/11/2010US20100286023 Compositions and Methods for Increasing Muscle Mass, Strength, and Functional Performance in the Elderly
11/11/2010US20100285448 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
11/11/2010US20100285159 Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
11/11/2010US20100285154 Use of lignan compounds for treating or preventing inflammatory disease
11/11/2010US20100285137 Antibiotic/bone morphogenic protein formulation and method of treatment
11/11/2010US20100285134 Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
11/11/2010US20100285114 Pharmaceutical compositions of rhein or diacerein
11/11/2010US20100285094 Polymeric compositions and methods of making and using thereof
11/11/2010US20100285093 Methods and compositions for repair of cartilage using an in vivo bioreactor
11/11/2010US20100285092 biological repair of cartilage using a hybrid construct combining both an inert structure and living core;cell-matrix encapsulation devices for growing, proliferating, and/or differentiating cells into chondrocyte-like cells under mechanical stress; has inflatable/expandable balloon-like bio-polymers
11/11/2010US20100285091 biological repair of cartilage using a hybrid construct combining both an inert structure and living core;cell-matrix encapsulation devices for growing, proliferating, and/or differentiating cells into chondrocyte-like cells under mechanical stress; has inflatable/expandable balloon-like bio-polymers
11/11/2010US20100285090 biological repair of cartilage using a hybrid construct combining both an inert structure and living core;cell-matrix encapsulation devices for growing, proliferating, and/or differentiating cells into chondrocyte-like cells under mechanical stress; has inflatable/expandable balloon-like bio-polymers
11/11/2010US20100285087 Single phenothiazine enantiomers as agents for the prevention of bone loss
11/11/2010US20100285064 Adjuvant composition for vaccine
11/11/2010US20100285036 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
11/11/2010US20100285032 Estrogen receptor-related receptor gamma (err gamma) in bone and cartilage formation and methods and compositions relating to same
11/11/2010US20100285019 Anti-IL-17F Antibodies and Methods of Use Thereof
11/11/2010US20100285002 Treatment or prevention of inflammation by targeting cyclin d1
11/11/2010US20100284995 Temperature sensitive mutants of matrix metalloproteases and uses thereof
11/11/2010US20100284992 Phospholipase C and Method of Use
11/11/2010US20100284991 Methods for the Treatment and Diagnosis of Bone Mineral Density Related Diseases
11/11/2010US20100284979 Modulation of Tissue Fatty Acid Composition of a Host by Human Gut Bacteria
11/11/2010US20100284972 Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
11/11/2010US20100284919 Injectable Radio-Opaque Compositions for Tissue Augmentation
11/11/2010DE202010012099U1 Vitaminzusammensetzung und Darreichungsform umfassend Vitamin D3 geeignet für die Osteoporoseprophylaxe und/oder Behandlung A vitamin composition and dosage form comprising Vitamin D3 suitable for osteoporosis prophylaxis and / or treatment
11/11/2010CA2760890A1 Anti-cd100 antibodies and methods for using the same
11/11/2010CA2760877A1 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
11/11/2010CA2760794A1 Egfr inhibitors and methods of treating disorders
11/10/2010EP2248898A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/10/2010EP2248897A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/10/2010EP2248896A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/10/2010EP2248801A1 Inhibitors of cytosolic phospholipase a2
11/10/2010EP2248528A1 Use of compositions comprising Dkk2 and fragments thereof for the stimulation or enhancement of bone formation
11/10/2010EP2247594A1 Pyrrolopyrimidinecarboxamides
11/10/2010EP2247290A1 Polyphenols for the treatment of cartilage disorders
11/10/2010EP2114888B1 Tricyclic compounds and their use as glucocorticoid receptor modulators
11/10/2010EP1940407B1 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
11/10/2010EP1833840B9 Potent lna oligonucleotides for the inhibition of hif-1a
11/10/2010EP1513589B1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
11/10/2010EP1401433B1 Azole acid derivatives, alone or in combination, for treating diabetes and dyslipidemias; and for treating malignant diseases
11/10/2010EP1181274B1 Iminocyclitol inhibitors of hexoaminidase and glycosidase
11/10/2010CN1943758B A Chinese traditional medicinal composition for treatment of rheumatism and its preparation method
11/10/2010CN1918134B Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors
11/10/2010CN101883779A Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
11/10/2010CN101883772A Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
11/10/2010CN101883765A Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
11/10/2010CN101883758A Aryl amides useful as inhibitors of voltage-gated sodium channels
11/10/2010CN101880701A New method for preparing aprotinin derivatives by using methanol yeast
11/10/2010CN101880646A Leachii mycoplasma Chinese isolate and isolation medium and application thereof
11/10/2010CN101880283A Azaindole kinase inhibitors
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/10/2010CN101879304A Functions of placenta polypeptide injection in treating bone injury and healing wound surfaces
11/10/2010CN101879286A Special wine for adjusting human spirit and preparation process thereof
11/10/2010CN101879264A Chinese medicinal composition for reducing blood uric acid
11/10/2010CN101879262A Chinese medicinal composition for treating femoral head necrosis
11/10/2010CN101879261A Medicinal paste for treating ischemic necrosis in head of femur
11/10/2010CN101879250A Arthralgia relief gel paste and preparation method
11/10/2010CN101879246A Traditional Chinese medicine for treating lupus erythematosus
11/10/2010CN101879245A Traditional Chinese medicine for treating femoral head necrosis
11/10/2010CN101879241A Method for extracting alkaloid from radix zanthoxyli
11/10/2010CN101879227A Chinese medicinal composition for treating protrusion of lumbar intervertebral disci and preparation method thereof
11/10/2010CN101879221A Medical application of caulis polygoni multiflori
11/10/2010CN101879213A Honeyed pill preparation for treating rheumatic arthritis
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 820